MKS Instruments, Inc. (NASDAQ:MKSI)‘s stock had its “outperform” rating reaffirmed by research analysts at KeyCorp in a report released on Saturday. They presently have a $100.00 target price on the scientific and technical instruments company’s stock. KeyCorp’s price target would suggest a potential upside of 15.47% from the company’s previous close.

MKSI has been the subject of a number of other reports. BidaskClub lowered shares of MKS Instruments from a “strong-buy” rating to a “buy” rating in a research note on Saturday, June 17th. Deutsche Bank AG initiated coverage on shares of MKS Instruments in a research note on Wednesday, July 5th. They set a “buy” rating and a $84.00 target price for the company. Stifel Nicolaus reissued a “buy” rating and set a $98.00 target price (up from $90.00) on shares of MKS Instruments in a research note on Thursday, July 27th. Finally, ValuEngine raised shares of MKS Instruments from a “hold” rating to a “buy” rating in a research note on Friday, June 2nd. Seven investment analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company’s stock. The company presently has an average rating of “Buy” and an average target price of $86.67.

Shares of MKS Instruments (NASDAQ:MKSI) opened at 86.60 on Friday. MKS Instruments has a 52-week low of $46.51 and a 52-week high of $88.40. The stock has a market capitalization of $4.70 billion, a PE ratio of 17.99 and a beta of 1.08. The stock has a 50 day moving average of $81.55 and a 200 day moving average of $75.92.

MKS Instruments (NASDAQ:MKSI) last posted its quarterly earnings data on Tuesday, July 25th. The scientific and technical instruments company reported $1.41 earnings per share for the quarter, meeting the Zacks’ consensus estimate of $1.41. MKS Instruments had a net margin of 15.47% and a return on equity of 19.47%. The business had revenue of $481.00 million for the quarter, compared to analysts’ expectations of $463.86 million. During the same quarter in the previous year, the business posted $0.72 earnings per share. The business’s revenue was up 47.6% compared to the same quarter last year. Analysts forecast that MKS Instruments will post $5.42 earnings per share for the current year.

WARNING: “KeyCorp Reaffirms “Outperform” Rating for MKS Instruments, Inc. (MKSI)” was first reported by American Banking News and is the sole property of of American Banking News. If you are viewing this news story on another site, it was illegally copied and reposted in violation of United States & international copyright legislation. The correct version of this news story can be viewed at https://www.americanbankingnews.com/2017/09/16/keycorp-reaffirms-outperform-rating-for-mks-instruments-inc-mksi.html.

In other news, Director Peter Hanley sold 1,000 shares of the business’s stock in a transaction on Friday, July 28th. The shares were sold at an average price of $83.22, for a total transaction of $83,220.00. Following the completion of the sale, the director now directly owns 3,372 shares of the company’s stock, valued at $280,617.84. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Seth H. Bagshaw sold 7,500 shares of the business’s stock in a transaction on Wednesday, September 13th. The shares were sold at an average price of $85.80, for a total transaction of $643,500.00. Following the sale, the chief financial officer now directly owns 21,615 shares of the company’s stock, valued at $1,854,567. The disclosure for this sale can be found here. Insiders have sold 11,100 shares of company stock valued at $935,105 over the last three months. Insiders own 1.65% of the company’s stock.

Large investors have recently added to or reduced their stakes in the stock. Riverhead Capital Management LLC lifted its stake in MKS Instruments by 71.9% in the second quarter. Riverhead Capital Management LLC now owns 2,063 shares of the scientific and technical instruments company’s stock worth $139,000 after acquiring an additional 863 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank lifted its stake in MKS Instruments by 47.8% in the first quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,201 shares of the scientific and technical instruments company’s stock worth $151,000 after acquiring an additional 712 shares during the period. Creative Planning lifted its stake in MKS Instruments by 22.8% in the second quarter. Creative Planning now owns 2,239 shares of the scientific and technical instruments company’s stock worth $151,000 after acquiring an additional 416 shares during the period. Good Life Advisors LLC purchased a new stake in MKS Instruments in the second quarter worth about $203,000. Finally, Suntrust Banks Inc. purchased a new stake in MKS Instruments in the first quarter worth about $209,000. 95.84% of the stock is owned by institutional investors.

About MKS Instruments

MKS Instruments, Inc is a global provider of instruments, subsystems and process control solutions that measures, controls, powers, delivers, monitors and analyzes critical parameters of advanced manufacturing processes. The Company operates through two segments, including the Vacuum & Analysis segment and the Light & Motion segment.

Analyst Recommendations for MKS Instruments (NASDAQ:MKSI)

Receive News & Ratings for MKS Instruments Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MKS Instruments Inc. and related companies with MarketBeat.com's FREE daily email newsletter.